{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-072869","form_type":"8-K","ticker":"KLRS","cik":"0001754068","company_name":"Kalaris Therapeutics, Inc.","filed_at":"2025-04-04T23:59:59+00:00","discovered_at":"2026-05-14T18:02:49.589682+00:00","generated_at":"2026-05-23T21:13:20.335885+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"confidence":"high","headline":"Kalaris Therapeutics appoints Leone Patterson to Board as Audit Committee Chair","bullets":["Leone Patterson elected Class III director effective April 3, 2025; term expires at 2026 annual meeting.","Patterson named Chair of Audit Committee; committee now includes Patterson, Adamis, and Jovan-Embiricos.","No arrangements or family relationships with other directors; standard indemnification agreement to be entered.","Company expects to adopt new non-employee director compensation program; Patterson will receive compensation once adopted."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-072869","json":"https://secwatch.observer/filing/0001193125-25-072869.json","markdown":"https://secwatch.observer/filing/0001193125-25-072869.md","text":"https://secwatch.observer/filing/0001193125-25-072869.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1754068/000119312525072869/0001193125-25-072869-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1754068/000119312525072869/d891759d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-23T21:13:20.335885+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"695c30f8e3","claim":"Leone Patterson was elected as Director and Chair of Audit Committee at Kalaris Therapeutics, Inc..","evidence_excerpt":"On April 3, 2025, upon the recommendation of the Nominating and Corporate Governance Committee of the Board of Directors (the “Board”) of Kalaris Therapeutics, Inc. (the “Company”), the Board elected Leone Patterson to serve as a member of the Board, effective immediately.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1754068/000119312525072869/0001193125-25-072869-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"elected"},{"label":"Role","value":"Director and Chair of Audit Committee"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}